Leukemia Treatment

About Leukemia Treatment

Leukemia — cancer of the blood-forming cells in the bone marrow — is treated in India by dedicated hemato-oncology teams with access to advanced diagnostics, including flow cytometry, cytogenetics, and molecular testing, which are essential for classifying the exact subtype (acute or chronic, lymphocytic or myeloid) and choosing the right protocol. Treatment typically starts with induction chemotherapy to bring the disease into remission, followed by consolidation therapy to eliminate remaining leukemic cells; some subtypes, such as chronic myeloid leukemia, are managed with targeted oral therapies (tyrosine kinase inhibitors) instead of intensive chemotherapy. For high-risk or relapsed cases, a bone marrow or stem cell transplant may be recommended, using either a matched sibling or unrelated donor, or the patient's own cells. Care is delivered in specialized hematology units with reverse-isolation rooms, blood bank support, and infection-control protocols suited to immunocompromised patients during treatment. Because leukemia protocols run over months, many patients coordinate an initial intensive phase in India with follow-up chemotherapy monitored by their home physician, with regular reports shared between teams to keep the treatment plan on track.